pharma · CDK Gene Mutation · Solid Tumor, Adult · KZIA
Kazia Therapeutics
KAZIA THERAPEUTICS LTD
NovaPharmaNews editorial coverage mentioning Kazia Therapeutics — regulatory, clinical, and market analysis.
300 Barangaroo Ave, L24, Barangaroo, New South Wales 2000, AU HQ
2016 Founded
15 Employees
Public company Type
KZIA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 300 Barangaroo Ave, L24, Barangaroo, New South Wales 2000, AU
- Founded
- 2016
- Employees
- 15
- Programs
- 13
- Drugs
- 9
- Patents
- 1
News & analysis
NovaPharmaNews articles mentioning Kazia Therapeutics — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Kazia Therapeutics — regulatory, clinical, and market analysis.
